This study found that the increased hepatic BCL6 expression sufficiently inhibits CD36 gene expression and subsequent hepatic lipid accumulation, while also exerting a positive effect on insulin resistance in HFD-fed mice. The gene discussed is CD36; the disease is Insulin resistance.